Prophylactic N-acetylcysteine Decreases Serum CRP but Not PCT Levels and Microalbuminuria Following Major Abdominal Surgery. A Prospective, Randomised, Double-blinded, Placebo-controlled Clinical Trial

Overview

Journal Intensive Care Med

Specialty Critical Care

Date 2003 Apr 19

PMID 12682719

Citations 10

Authors

Zsolt Molnar

Tamas Szakmany

Tamas Koszegi

Affiliations

Soon will be listed here.

Abstract

Objective: Our objective was to investigate whether short-term infusion of the oxygen free radical scavenger N-acetylcysteine (NAC) administered before and during extensive abdominal surgery could ameliorate the progression of early systemic inflammatory response.

Design: Prospective, randomised, double-blinded, placebo-controlled clinical trial.

Setting: Twenty-bed intensive care unit in a university hospital.

Patients: Following written informed consent, 100 patients were randomised into NAC and placebo groups. Three patients from the NAC group and four from the placebo group withdrew before the final analysis.

Intervention: The treatment group (n=47) received NAC (150 mg/kg(-1) bolus followed by a continuous infusion of 12 mg/kg(-1)/h(-1)) and the placebo group ( n=46) received the same volume of 5% dextrose during surgery.

Measurements And Results: Serum procalcitonin (PCT), C-reactive protein (CRP) and microalbuminuria was monitored preoperatively, on admission to ICU, then daily during the first 3 postoperative days. For statistical analysis Mann Whitney and Chi-squared tests were used. Patients' clinical course was similar in each group as monitored by the Multiple Organ Dysfunction Scores. There was no significant difference between the two groups regarding PCT and microalbuminuria at any assessment point. Significantly lower CRP levels were found in the NAC group on days 1 and 2 (t(24): median: 84.5 interquartile range: [62-120] vs. 118 [86-137] mg/l; p=0.020; t(48): 136 [103-232] vs. 195 [154-252] mg/l; p=0.013, NAC vs. placebo respectively).

Conclusion: In this study, short-term NAC treatment decreased CRP levels, but failed to attenuate any other inflammatory response, as monitored by serum PCT and microalbuminuria. Overall, our results do not support the routine prophylactic use of NAC as a free radical scavenger in abdominal surgery.

Citing Articles

Preventing the development of severe COVID-19 by modifying immunothrombosis.

Morris G, Bortolasci C, Puri B, Olive L, Marx W, ONeil A Life Sci. 2020; 264:118617.

PMID: 33096114 PMC: 7574725. DOI: 10.1016/j.lfs.2020.118617.

Supplemental N-acetylcysteine and other measures that boost intracellular glutathione can downregulate interleukin-1β signalling: a potential strategy for preventing cardiovascular events?.

DiNicolantonio J, OKeefe J, McCarty M Open Heart. 2017; 4(2):e000599.

PMID: 28878946 PMC: 5574421. DOI: 10.1136/openhrt-2017-000599.

Advances in the Diagnosis of Sepsis.

EJIFCC. 2017; 28(2):99-103.

PMID: 28757817 PMC: 5460007.

Section 4: Contrast-induced AKI.

Kidney Int Suppl (2011). 2014; 2(1):69-88.

PMID: 25018920 PMC: 4089629. DOI: 10.1038/kisup.2011.34.

Section 3: Prevention and Treatment of AKI.

Kidney Int Suppl (2011). 2014; 2(1):37-68.

PMID: 25018919 PMC: 4089747. DOI: 10.1038/kisup.2011.33.

References

Aruoma O, Halliwell B, Hoey B, Butler J . The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med. 1989; 6(6):593-7. DOI: 10.1016/0891-5849(89)90066-x. View

Meisner M, Tschaikowsky K, Schnabel S, Schmidt J, Katalinic A, Schuttler J . Procalcitonin--influence of temperature, storage, anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations. Eur J Clin Chem Clin Biochem. 1997; 35(8):597-601. DOI: 10.1515/cclm.1997.35.8.597. View

Nylen E, Whang K, Snider Jr R, Steinwald P, White J, Becker K . Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med. 1998; 26(6):1001-6. DOI: 10.1097/00003246-199806000-00015. View

Ogilvie A, Groeneveld A, Straub J, Thijs L . Plasma lipid peroxides and antioxidants in human septic shock. Intensive Care Med. 1991; 17(1):40-4. DOI: 10.1007/BF01708408. View

Svanes K, Stangeland L, Viste A, Varhaug J, Gronbech J, Soreide O . Morbidity, ability to swallow, and survival, after oesophagectomy for cancer of the oesophagus and cardia. Eur J Surg. 1995; 161(9):669-75. View

Okamura J, Miyagi J, Terada K, Hokama Y . Potential clinical applications of C-reactive protein. J Clin Lab Anal. 1990; 4(3):231-5. DOI: 10.1002/jcla.1860040316. View

Russwurm S, Stonans I, Stonane E, Wiederhold M, Luber A, Zipfel P . Procalcitonin and CGRP-1 mrna expression in various human tissues. Shock. 2001; 16(2):109-12. DOI: 10.1097/00024382-200116020-00004. View

Kerbaul F, Guidon C, Lejeune P, Mollo M, Mesana T, Gouin F . Hyperprocalcitonemia is related to noninfectious postoperative severe systemic inflammatory response syndrome associated with cardiovascular dysfunction after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2002; 16(1):47-53. DOI: 10.1053/jcan.2002.29672. View

Molnar Z, Szakmany T, Koszegi T, TEKERES M . Microalbuminuria and serum procalcitonin levels following oesophagectomy. Eur J Anaesthesiol. 2000; 17(7):464-5. View

10.

Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schuttler J . Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med. 1998; 24(7):680-4. DOI: 10.1007/s001340050644. View

11.

Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau G . Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001; 164(3):396-402. DOI: 10.1164/ajrccm.164.3.2009052. View

12.

Jepsen S, Herlevsen P, Knudsen P, Bud M, Klausen N . Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study. Crit Care Med. 1992; 20(7):918-23. DOI: 10.1097/00003246-199207000-00004. View

13.

Molnar Z, MACKINNON K, Shearer E, Lowe D, Watson I . The effect of N-acetylcysteine on total serum anti-oxidant potential and urinary albumin excretion in critically ill patients. Intensive Care Med. 1998; 24(3):230-5. DOI: 10.1007/s001340050555. View

14.

Marshall J, Cook D, Christou N, Bernard G, Sprung C, Sibbald W . Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995; 23(10):1638-52. DOI: 10.1097/00003246-199510000-00007. View

15.

Watts G, Morris R, Khan K, Polak A . Urinary albumin excretion in healthy adult subjects: reference values and some factors affecting their interpretation. Clin Chim Acta. 1988; 172(2-3):191-8. DOI: 10.1016/0009-8981(88)90323-3. View

16.

Suter P, Domenighetti G, Schaller M, Laverriere M, Ritz R, Perret C . N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study. Chest. 1994; 105(1):190-4. DOI: 10.1378/chest.105.1.190. View

17.

Spies C, Reinhart K, Witt I, Meier-Hellmann A, Hannemann L, Bredle D . Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study. Crit Care Med. 1994; 22(11):1738-46. View

18.

Goode H, Cowley H, Walker B, Howdle P, Webster N . Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med. 1995; 23(4):646-51. DOI: 10.1097/00003246-199504000-00011. View

19.

Peristeris P, Clark B, Gatti S, Faggioni R, Mantovani A, Mengozzi M . N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production. Cell Immunol. 1992; 140(2):390-9. DOI: 10.1016/0008-8749(92)90205-4. View

20.

Castell J, Gomez-Lechon M, David M, Fabra R, Trullenque R, Heinrich P . Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology. 1990; 12(5):1179-86. DOI: 10.1002/hep.1840120517. View